Novamind psychedelic stock4/25/2023 ![]() Novamind is a leading mental health company enabling safe access to psychedelic medicine through a network of clinics and clinical research sites. To learn more about Novamind's clinical research division, visit About Novamind "We anticipate that this progress will accelerate the approval process for us to become a research site for additional psychedelic clinical studies in the future." Thielking, who last week launched Psychedelic Palliative Care by Novamind, a first of its kind program to support the mental health of patients and families struggling with serious illness. Psilocybin has shown significant positive outcomes for people with major depressive disorder1 and for reducing anxiety and depression in people with life-threatening cancer.2 As of today, there are over 50 clinical studies actively examining the use of psilocybin, as listed on "The DEA Licenses are timely," said Dr. ![]() This milestone reflects our expertise and enables us to continue on our mission to create breakthroughs in mental health treatment." "We're proud of our clinical research organization's track record investigating innovative solutions for central nervous system conditions. "Obtaining the DEA Licenses is a critical step towards hosting clinical trials for psilocybin-assisted psychotherapy," commented Dr. The DEA Licenses are required for research sites planning to host clinical trials for psilocybin, enabling principal investigators to store and administer this controlled substance. Paul Thielking, Chief Scientific Officer. Reid Robison, Chief Medical Officer, and Dr. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine is pleased to announce it has been granted Schedule 1 licenses (the "DEA Licenses") from the U.S. TORONTO, ON / ACCESSWIRE / Octo/ Novamind Inc. Novamind logo by N/A is licensed under Novamind Inc Licenses a key step in hosting contracted clinical trials for Schedule 1 controlled substances
0 Comments
Leave a Reply.AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |